Genetic/familial high-risk assessment: Colorectal version 1.2016: Clinical practice guidelines in oncology Journal Article


Authors: Provenzale, D.; Gupta, S.; Ahnen, D. J.; Bray, T.; Cannon, J. A.; Cooper, G.; David, D. S.; Early, D. S.; Erwin, D.; Ford, J. M.; Giardiello, F. M.; Grady, W.; Halverson, A. L.; Hamilton, S. R.; Hampel, H.; Ismail, M. K.; Klapman, J. B.; Larson, D. W.; Lazenby, A. J.; Lynch, P. M.; Mayer, R. J.; Ness, R. M.; Regenbogen, S. E.; Samadder, N. J.; Shike, M.; Steinbach, G.; Weinberg, D.; Dwyer, M.; Darlow, S.
Article Title: Genetic/familial high-risk assessment: Colorectal version 1.2016: Clinical practice guidelines in oncology
Abstract: This is a focused update highlighting the most current NCCN Guidelines for diagnosis and management of Lynch syndrome. Lynch syndrome is the most common cause of hereditary colorectal cancer, usually resulting from a germline mutation in 1 of 4 DNA mismatch repair genes (MLH1, MSH2, MSH6, or PMS2), or deletions in the EPCAM promoter. Patients with Lynch syndrome are at an increased lifetime risk, compared with the general population, for colorectal cancer, endometrial cancer, and other cancers, including of the stomach and ovary. As of 2016, the panel recommends screening all patients with colorectal cancer for Lynch syndrome and provides recommendations for surveillance for early detection and prevention of Lynch syndrome-associated cancers.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 14
Issue: 8
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2016-08-01
Start Page: 1010
End Page: 1030
Language: English
PROVIDER: scopus
PUBMED: 27496117
DOI/URL:
Notes: Article -- Export Date: 1 September 2016 -- Source: Scopus
Citation Impact
MSK Authors
  1. Moshe Shike
    168 Shike